These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)]. Dimroth H. Med Klin; 1979 Jun 01; 74(22):875-6. PubMed ID: 470785 [Abstract] [Full Text] [Related]
5. [Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)]. Wolfram G, Keller C, Kilani S, Zöllner N. Dtsch Med Wochenschr; 1976 Jan 16; 101(3):76-81. PubMed ID: 1245160 [Abstract] [Full Text] [Related]
7. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)]. Proto C, Quadri A, Ratti S, Levi GF, Prandini BD. G Ital Cardiol; 1978 Jan 16; 8(7):743-51. PubMed ID: 355033 [Abstract] [Full Text] [Related]
8. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia]. Arntz HR, Klemens UH, Vollmar LJ, Lang PD. Med Klin; 1978 Dec 08; 73(49):1731-7. PubMed ID: 723760 [Abstract] [Full Text] [Related]
9. [Drugs which decrease serum lipids]. Oye I. Tidsskr Nor Laegeforen; 1973 Jan 10; 93(1):32-3. PubMed ID: 4691222 [No Abstract] [Full Text] [Related]
10. [Serum lipid-lowering drugs following myocardial infarction]. Schettler G. Dtsch Med Wochenschr; 1975 Aug 01; 100(31):1611-2. PubMed ID: 168052 [No Abstract] [Full Text] [Related]
12. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia]. Sterner W, Schultz A. Arzneimittelforschung; 1974 Dec 01; 24(12):1990-2. PubMed ID: 4480360 [No Abstract] [Full Text] [Related]
14. [Field study on the decrease of lipids using etofibrate]. Schneider J, Haase W, Kaffarnik H. Fortschr Med; 1976 May 06; 94(13):785-90. PubMed ID: 8362 [Abstract] [Full Text] [Related]
15. [Dose-effects studies with bezafibrate in patients with hypercholesterolemia and hypertriglyceridemia (author's transl)]. Adam O, Wolfram G, Lang PD, Zöllner N. MMW Munch Med Wochenschr; 1979 Mar 02; 121(9):319-22. PubMed ID: 106264 [Abstract] [Full Text] [Related]
16. [Influence of etofibrate on plasmaviscosity in hyperlipoproteinemias (author's transl)]. Pfeiffer M, Tilsner V. Med Klin; 1978 Jan 13; 73(2):60-2. PubMed ID: 622057 [No Abstract] [Full Text] [Related]
17. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia. Orö L, Olsson AG, Rössner S, Carlson LA. Postgrad Med J; 1975 Jan 13; 51(8):suppl 76-81. PubMed ID: 215986 [Abstract] [Full Text] [Related]
18. [Letter: Etofibrate and clofibrate in double blind study]. Knipping W, Kaffarnik H, Schneider J, Haase W. Dtsch Med Wochenschr; 1976 Apr 16; 101(16):627-9. PubMed ID: 770108 [No Abstract] [Full Text] [Related]
19. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate]. Gaertner U, Johannes KJ. MMW Munch Med Wochenschr; 1976 Sep 03; 118(36):1127-30. PubMed ID: 184377 [Abstract] [Full Text] [Related]
20. [Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)]. Koschinsky T, Lenhard P, Gries FA, Vogelberg KH, Wolfram G, Lang PD, Vollmar J. Med Klin; 1977 Sep 23; 72(38):1537-43. PubMed ID: 904549 [Abstract] [Full Text] [Related] Page: [Next] [New Search]